Therapy for HER2-Positive Metastatic Breast Cancer von Dekker, Tim J.A, Winer, Eric P

Volltext

Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives von Rozeman, Elisa A., Dekker, Tim J. A., Haanen, John B. A. G., Blank, Christian U.

Volltext

Ripretinib for advanced gastrointestinal stromal tumours von Dekker, Tim J A

Volltext

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study von Roeke, Toni, Sobral-Leite, Marcelo, Dekker, Tim J. A., Wesseling, Jelle, Smit, Vincent T. H. B. M., Tollenaar, Rob A. E. M., Schmidt, Marjanka K., Mesker, Wilma E.

Volltext

Oncogene Up-Regulation after Hypomethylating Therapy von Dekker, Tim J.A., Voso, Maria T., Tenen, Daniel G., Chai, Li

Volltext

Towards imaging metabolic pathways in tissues von Dekker, Tim J. A., Jones, Emrys A., Corver, Willem E., van Zeijl, René J. M., Deelder, André M., Tollenaar, Rob A. E. M., Mesker, Wilma E., Morreau, Hans, McDonnell, Liam A.

Volltext

The prognostic value of tumor–stroma ratio in tumor‐positive axillary lymph nodes of breast cancer patients von Vangangelt, Kiki M.H., Tollenaar, Lisanne S.A., van Pelt, Gabi W., de Kruijf, Esther M., Dekker, Tim J.A., Kuppen, Peter J.K., Tollenaar, Rob A.E.M., Mesker, Wilma E.

Volltext

Tirzepatide Once Weekly for the Treatment of Obesity von Dekker, Tim J.A., Hagerich, Kelley, Durkee, Melissa, Goldstein, Michael G., Venniyoor, Ajit, Jastreboff, Ania M., Aronne, Louis J., Stefanski, Adam

Volltext

PARP Inhibitors in Ovarian Cancer von Dekker, Tim J. A.

Volltext

Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas von de Haan, Lorraine M., de Groen, Ruben A. L., de Groot, Fleur A., Noordenbos, Troy, van Wezel, Tom, van Eijk, Ronald, Ruano, Dina, Diepstra, Arjan, Koens, Lianne, Nicolae-Cristea, Alina, Hartog, Wietske C. E. den, Terpstra, Valeska, Ahsmann, Els, Dekker, Tim J. A., Sijs-Szabo, Aniko, Veelken, Hendrik, Cleven, Arjen H. G., Jansen, Patty M., Vermaat, Joost S. P.

Volltext

Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer von van Golen, Rowan F., Dekker, Tim J. A.

Volltext

Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling von Zhou, FangFang, Drabsch, Yvette, Dekker, Tim J. A., de Vinuesa, Amaya Garcia, Li, Yihao, Hawinkels, Lukas J. A. C., Sheppard, Kelly-Ann, Goumans, Marie-José, Luwor, Rodney B., de Vries, Carlie J., Mesker, Wilma E., Tollenaar, Rob A. E. M., Devilee, Peter, Lu, Chris X., Zhu, Hongjian, Zhang, Long, Dijke, Peter ten

Volltext

Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer von Hagenaars, Sophie C., Groot, Stefanie, Cohen, Danielle, Dekker, Tim J. A., Charehbili, Ayoub, Meershoek‐Klein Kranenbarg, Elma, Duijm‐de Carpentier, Marjolijn, Pijl, Hanno, Putter, Hein, Tollenaar, Rob A. E. M., Kroep, Judith R., Mesker, Wilma E.

Volltext

Multicenter Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) Identifies Proteomic Differences in Breast-Cancer-Associated Stroma von Dekker, Tim J. A, Balluff, Benjamin D, Jones, Emrys A, Schöne, Cédrik D, Schmitt, Manfred, Aubele, Michaela, Kroep, Judith R, Smit, Vincent T. H. B. M, Tollenaar, Rob A. E. M, Mesker, Wilma E, Walch, Axel, McDonnell, Liam A

Volltext

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach von Dekker, Tim J A, Borg, Susan Ter, Hooijer, Gerrit K J, Meijer, Sybren L, Wesseling, Jelle, Boers, James E, Schuuring, Ed, Bart, Jos, van Gorp, Joost, Mesker, Wilma E, Kroep, Judith R, Smit, Vincent T H B M, van de Vijver, Marc J

Volltext

PARP Inhibitors in Ovarian Cancer von da Costa, Alexandre, Haines, Ian E, Gabor Miklos, George L, Dekker, Tim J.A, González-Martín, Antonio, Monk, Bradley J, Ray-Coquard, Isabelle, Pérol, David, Pujade-Lauraine, Eric

Volltext

Fulvestrant plus capivasertib for metastatic breast cancer von Dekker, Tim Johannes Adrianus

Volltext

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation... von de Groot, Fleur A., Dekker, Tim J.A., Doorduijn, Jeanette K., Böhringer, Stefan, Brink, Mirian, de Groen, Ruben A.L., de Haan, Lorraine M., Woei-A-Jin, F.J. Sherida H., Noordenbos, Troy, Sijs-Szabo, Aniko, Oudshoorn, Mirjam A., Lam, King H., Diepstra, Arjan, te Boome, Liane C.J., Terpstra, Valeska, Bohmer, Lara H., Nicolae, Alina, Posthuma, Eduardus F.M., Koens, Lianne, Durian, Marc F., Stavast, Jeroen, van der Poel, Marjolein W.M., Hamid, Myrurgia Abdul, Stevens, Wendy B.C., van Rooij, Sjo L.M., Oostvogels, Rimke S., Mühlebner, Angelika, Neelis, Karen J., van den Brand, Michiel, Tousseyn, Thomas, Dierickx, Daan, de Weerdt, Okke, Beeker, Aart, Jansen, Patty M., Kersten, Marie José, Zijlstra, Josée M., Chamuleau, Martine E.D., Veelken, Hendrik, Bromberg, Jacoline C.E., Nijland, Marcel, Vermaat, Joost S.P.

Volltext

HER2-Targeted Therapies in HER2-Low-Expressing Breast Cancer von Dekker, Tim Johannes Adrianus

Volltext

Neratinib in HER2-Positive Breast Cancer With Brain Metastases von Dekker, Tim Johannes Adrianus

Volltext